| CYSB2400300 | 门冬胰岛素30注射液 | Insulin aspart protamine recombinant;insulin aspart recombinant | Injection | Biological Products | Supplementary Application | 2024-11-14 | | Gan & Lee Pharmaceuticals | | | view |
| CYSB2400288 | 门冬胰岛素30注射液 | Insulin aspart protamine recombinant;insulin aspart recombinant | Injection | Biological Products | Supplementary Application | 2024-11-05 | | Gan & Lee Pharmaceuticals | | | view |
| CYSB2400219 | 门冬胰岛素30注射液 | Insulin aspart protamine recombinant;insulin aspart recombinant | Injection | Biological Products | Supplementary Application | 2024-08-17 | | Tonghua Dongbao Pharmaceutical Co Ltd | | | view |
| CYSB2400167 | 门冬胰岛素30注射液 | Insulin aspart protamine recombinant;insulin aspart recombinant | Injection | Biological Products(3.3) | Supplementary Application | 2024-07-02 | | Yichang HEC Changjiang Pharmaceutical Co Ltd | | | view |
| CXSL2400365 | 门冬胰岛素30注射液 | Insulin aspart protamine recombinant;insulin aspart recombinant | Injection | Biological Products(3.3) | New Drug Application | 2024-06-04 | | Ningbo Kunpeng BIOTECH Co Ltd | | | view |
| CYSB2400139 | 门冬胰岛素30注射液 | Insulin aspart protamine recombinant;insulin aspart recombinant | Injection | Biological Products | Supplementary Application | 2024-06-01 | | Gan & Lee Pharmaceuticals | | | view |
| CYSB2400063 | 门冬胰岛素30注射液 | Insulin aspart protamine recombinant;insulin aspart recombinant | Injection | Biological Products | Supplementary Application | 2024-03-08 | | Novo Nordisk (China) Pharmaceuticals Co Ltd | | | view |
| CYSB2300010 | 门冬胰岛素30注射液 | Insulin aspart protamine recombinant;insulin aspart recombinant | Injection | Biological Products | Supplementary Application | 2023-01-11 | | Zhuhai United Laboratories Co Ltd | | | view |
| CYSB2300011 | 门冬胰岛素30注射液 | Insulin aspart protamine recombinant;insulin aspart recombinant | Injection | Biological Products | Supplementary Application | 2023-01-11 | | Zhuhai United Laboratories Co Ltd | | | view |
| CYSB2200124 | 门冬胰岛素30注射液 | Insulin aspart protamine recombinant;insulin aspart recombinant | Injection | Biological Products | Supplementary Application | 2022-05-31 | | Gan & Lee Pharmaceuticals | | | view |
| CXSS2200009 | 门冬胰岛素30注射液 | Insulin aspart protamine recombinant;insulin aspart recombinant | Injection | Biological Products(3.3) | New Drug Application | 2022-01-28 | | Jilin Huisheng Biopharmaceutical Co Ltd | | | view |
| JYSB2200002 | 门冬胰岛素30注射液 | Insulin aspart protamine recombinant;insulin aspart recombinant | Injection | Biological Products | Supplementary Application | 2022-01-06 | | Novo Nordisk A/S | | | view |
| CYSB2200004 | 门冬胰岛素30注射液 | Insulin aspart protamine recombinant;insulin aspart recombinant | Injection | Biological Products | Supplementary Application | 2022-01-06 | | Novo Nordisk (China) Pharmaceuticals Co Ltd | | | view |
| CYSB2200005 | 门冬胰岛素30注射液 | Insulin aspart protamine recombinant;insulin aspart recombinant | Injection | Biological Products | Supplementary Application | 2022-01-06 | | Novo Nordisk (China) Pharmaceuticals Co Ltd | | | view |
| JYSB2200003 | 门冬胰岛素30注射液 | Insulin aspart protamine recombinant;insulin aspart recombinant | Injection | Biological Products | Supplementary Application | 2022-01-06 | | Novo Nordisk A/S | | | view |
| CXSS2101012 | 门冬胰岛素30注射液 | Insulin aspart protamine recombinant;insulin aspart recombinant | Injection | Biological Products(3.4) | New Drug Application | 2021-07-14 | | Tonghua Dongbao Pharmaceutical Co Ltd | | | view |
| CYSB2101049 | 门冬胰岛素30注射液 | Insulin aspart protamine recombinant;insulin aspart recombinant | Injection | Biological Products | Supplementary Application | 2021-04-23 | | Gan & Lee Pharmaceuticals | | | view |
| CXSS2100019 | 门冬胰岛素30注射液 | Insulin aspart protamine recombinant;insulin aspart recombinant | Injection | Biological Products(3.3) | New Drug Application | 2021-02-11 | 宜昌东阳光长江药业股份有限公司 | Yichang HEC Changjiang Pharmaceutical Co Ltd | In Review | 2021-02-10 | view |
| JYSB2000231 | 门冬胰岛素30注射液 | Insulin aspart protamine recombinant;insulin aspart recombinant | Injection | Biological Products | Supplementary Application | 2020-06-05 | 丹麦诺和诺德公司 | Novo Nordisk A/S | Filed | 2020-06-11 | view |
| JYSB2000230 | 门冬胰岛素30注射液 | Insulin aspart protamine recombinant;insulin aspart recombinant | Injection | Biological Products | Supplementary Application | 2020-06-05 | 丹麦诺和诺德公司 | Novo Nordisk A/S | Filed | 2020-06-11 | view |
